Quality of life, characteristics and survival of patients with HIV and lymphoma

被引:16
作者
Diamond, Catherine [1 ,2 ]
Taylor, Thomas H. [1 ]
Anton-Culver, Hoda [1 ]
机构
[1] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
基金
美国国家卫生研究院;
关键词
HIV; AIDS; Quality of life; Non-Hodgkin lymphoma; FAHI; FACT G; NON-HODGKINS-LYMPHOMA; FUNCTIONAL ASSESSMENT; CANCER; VALIDATION; THERAPY; INSTRUMENT; AIDS;
D O I
10.1007/s11136-009-9565-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We sought to compare the quality of life (QOL), characteristics, and survival of patients with non-Hodgkin lymphoma (NHL) with and without human immunodeficiency virus (HIV) infection. Using the population-based cancer registry for Orange and San Diego Counties, We recruited 50 patients with HIV and systemic NHL (cases) and 50 age, sex and race-matched NHL patients without HIV (controls) diagnosed with NHL during 2002-2006. Patients completed a medical history survey and QOL instrument, the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) for cases and Functional Assessment of Cancer Therapy-General (FACT G) for controls. HIV-infected patients had worse overall QOL and survival than uninfected patients. QOL differences were more marked in the areas of functional, physical and social well-being than in the area of emotional well-being. HIV-infected patients had lower income and were less likely to have private insurance and more likely to have diffuse large B cell histology than uninfected patients. HIV-infected NHL patients had worse QOL and survival than uninfected patients, due to a combination of co-morbidity, aggressive histology and lack of social support. However, their emotional well-being was comparable to that of uninfected NHL patients and better than historical norms for the HIV-infected.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 21 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]   Physical Activity and Quality of Life in Adult Survivors of Non-Hodgkin's Lymphoma [J].
Bellizzi, Keith M. ;
Rowland, Julia H. ;
Arora, Neeraj K. ;
Hamilton, Ann S. ;
Miller, Melissa Farmer ;
Aziz, Noreen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) :960-966
[3]   AIDS-Related cancer and severity of immunosuppression in persons with AIDS [J].
Biggar, Robert J. ;
Chaturvedi, Anil K. ;
Goedert, James J. ;
Engels, Eric A. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) :962-972
[4]   Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma [J].
Boue, Francois ;
Gabarre, Jean ;
Gisselbrecht, Christian ;
Reynes, Jacques ;
Cheret, Antoine ;
Bonnet, Fabrice ;
Billaud, Eric ;
Raphael, Martine ;
Lancar, Remi ;
Costagliola, Dominique .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4123-4128
[5]   General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G) [J].
Brucker, PS ;
Yost, K ;
Cashy, J ;
Webster, K ;
Cella, D .
EVALUATION & THE HEALTH PROFESSIONS, 2005, 28 (02) :192-211
[6]  
*CDCP, 2005, HIV AIDS SURVEILLA S, V11, P12
[7]  
*CDCP, 2009, 1912 US DEP HHS CDCP
[8]   Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument [J].
Cella, D ;
Hernandez, L ;
Bonomi, AE ;
Corona, M ;
Vaquero, M ;
Shiomoto, G ;
Baez, L .
MEDICAL CARE, 1998, 36 (09) :1407-1418
[9]   Development and validation of the functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument [J].
Cella, DF ;
McCain, NL ;
Peterman, AH ;
Mo, F ;
Wolen, D .
QUALITY OF LIFE RESEARCH, 1996, 5 (04) :450-463
[10]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579